CDH1 and posterior cortical atrophy: E-cadherin protein expressions in the PCa+Docetaxel, PCa+LDH-A inhibitor, and PCa+LDH-A inhibitor + Docetaxel treatment groups increased significantly compared to the PCa group (p < 0.05, p < 0.01 and p < 0.05 respectively).